Edwards Lifesciences Aktie
78,90
EUR
+0,16
EUR
+0,20
%
89,65
USD
+2,68
USD
+3,08
%
Edwards Lifesciences jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Edwards Lifesciences Aktie Analyse
| 16.10.18 | Edwards Lifesciences Underweight | Barclays Capital | |
| 05.12.12 | Edwards Lifesciences sell | UBS AG | |
| 15.11.12 | Edwards Lifesciences sell | UBS AG | |
| 12.04.10 | Edwards Lifesciences verkaufen | Wedbush Morgan Securities Inc. | |
| 28.07.09 | Edwards Lifesciences underperform | Wedbush Morgan Securities Inc. | |
| 09.03.07 | Edwards Lifesciences underweight | Morgan Stanley | |
| 06.02.07 | Edwards Lifesciences Sell | Goldman Sachs | |
| 06.02.07 | Edwards Lifesciences Sell | Goldman Sachs | |
|
Werbung
|
|||
| 14.06.05 | Edwards Lifesciences Underperform | First Albany | |
Werbung
Werbung